Literature DB >> 8512109

Hypothermia eliminates isoflurane requirements at 20 degrees C.

J F Antognini1.   

Abstract

BACKGROUND: Hypothermia decreases anesthetic requirements, but the temperature that completely eliminates anesthetic needs has not been previously determined.
METHODS: Eight female goats were anesthetized with isoflurane and catheters were placed in the femoral artery and cranial vena cava, after which the right carotid artery and external jugular vein were dissected free. Peripheral temperature was monitored in the rectum and core temperature in the vena cava. A thermistor was placed in the epidural space via a small burr hole to monitor brain temperature. Minimum alveolar concentration (MAC) for isoflurane was determined by eliciting gross, purposeful movement with a tail clamp. Cardiopulmonary bypass (CPB) was established using bubble oxygenators with venous blood drained from a jugular vein and arterial blood infused with a roller pump into the carotid artery. The animals were cooled to approximately 29 degrees C, and MAC redetermined, after which further cooling to 20 degrees C was accomplished. Isoflurane was eliminated, core and brain temperature adjusted in 2-3 degrees C increments, and the tail clamp applied until two temperatures were found that just permitted and just prevented movement. The animals were rewarmed, isoflurane added, and post-CPB MAC determined.
RESULTS: At 38.5 degrees C, pre-CPB MAC was 1.3 +/- 0.1% (mean +/- SEM). At 29.0 degrees C, MAC was 0.7 +/- 0.1%, and the anesthetizing temperature was 20.1 +/- 0.6 degrees C. At 37.3 degrees C, post-CPB MAC was 1.0 +/- 0.1% (P < 0.05 vs. pre-CPB).
CONCLUSIONS: These results confirm the rectilinear decrease in MAC seen in previous studies and establishes the anesthetizing temperature at 20 degrees C.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8512109     DOI: 10.1097/00000542-199306000-00020

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  8 in total

Review 1.  [Pharmacokinetic-pharmacodynamic models for inhaled anaesthetics].

Authors:  S Kreuer; J Bruhn; W Wilhelm; T Bouillon
Journal:  Anaesthesist       Date:  2007-06       Impact factor: 1.041

Review 2.  Effects of Rodent Thermoregulation on Animal Models in the Research Environment.

Authors:  F Claire Hankenson; James O Marx; Christopher J Gordon; John M David
Journal:  Comp Med       Date:  2018-11-20       Impact factor: 0.982

3.  Hypothermia decreases ethanol MAC in rats.

Authors:  Albert Won; Irene Oh; Robert Brosnan; Edmond I Eger; James M Sonner
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

Review 4.  Brain monitoring with electroencephalography and the electroencephalogram-derived bispectral index during cardiac surgery.

Authors:  Miklos D Kertai; Elizabeth L Whitlock; Michael S Avidan
Journal:  Anesth Analg       Date:  2012-01-17       Impact factor: 5.108

5.  Assessing changes in volatile general anesthetic sensitivity of mice after local or systemic pharmacological intervention.

Authors:  Hilary S McCarren; Jason T Moore; Max B Kelz
Journal:  J Vis Exp       Date:  2013-10-16       Impact factor: 1.355

6.  The effects of temperature on the interactions between volatile general anaesthetics and a neuronal nicotinic acetylcholine receptor.

Authors:  R Dickinson; W R Lieb; N P Franks
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

Review 7.  Is a new paradigm needed to explain how inhaled anesthetics produce immobility?

Authors:  Edmond I Eger; Douglas E Raines; Steven L Shafer; Hugh C Hemmings; James M Sonner
Journal:  Anesth Analg       Date:  2008-09       Impact factor: 5.108

8.  Increases in spinal cerebrospinal fluid potassium concentration do not increase isoflurane minimum alveolar concentration in rats.

Authors:  Dimitry Shnayderman; Michael J Laster; Edmond I Eger; Irene Oh; Yi Zhang; Steven L Jinks; Joseph F Antognini; Douglas E Raines
Journal:  Anesth Analg       Date:  2008-09       Impact factor: 5.108

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.